NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
Schuliga M. · 2015
Read NF-kappaB Signaling in Chronic Inflammatory Airway Disease. by Schuliga M. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4598751.txt.
Description
Michael Schuliga wrote a solo 2015 review of NF-kappaB signalling in long-term airway disease. Asthma and chronic obstructive pulmonary disease, or COPD, differ in cause but share airway inflammation. A protein complex called NF-kappaB switches on many inflammation genes, and oxidative stress activates it. The review appeared in the International Journal of Molecular Sciences.
Steroid drugs calm asthma partly by blocking NF-kappaB, yet in severe asthma and COPD that block fails after chemical changes to the steroid receptor and its partners. Drugs that block the enzymes which activate NF-kappaB are candidate treatments. Restoring the steroid block is another route the review weighs. Readers get a clear map of one central inflammation pathway and the treatment ideas built around it.
Catalog record
| CREATOR | Schuliga M. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |